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Signiﬁcant progress has been made in understanding the relationship between histone modiﬁca-
tions and ‘reader’ molecules and their effects on transcriptional regulation. A previously identiﬁed
INHAT complex subunit, SET/TAF-Ib, binds to histones and inhibits histone acetylation. To investi-
gate the binding speciﬁcities of SET/TAF-Ib to various histone modiﬁcations, we employed modiﬁed
histone tail peptide array analyses. SET/TAF-Ib strongly recognized PRC2-mediated H3K27me1/2/3;
however, the bindings were completely disrupted by H3S28 phosphorylation. We have demon-
strated that SET/TAF-Ib is sequentially recruited to the target gene promoter ATF3 after the PRC2
complex via H3K27me recognition and may offer additive effects in the repression of the target
gene.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Post-translational modiﬁcations of histone N-terminal tails
including acetylation, methylation, ubiquitination, and phosphory-
lation have been tightly linked to transcriptional regulation and
chromatin remodeling [1]. Signiﬁcant progress has been made
understanding the relationship between these modiﬁcations and
‘‘reader’’ molecules, which recognize histone modiﬁcations, and
their effects on diverse signaling pathways, such as speciﬁc tran-
scriptional regulation of target genes. These modiﬁcations function
as a signal platform to recruit the reader molecules to the pro-
moter, which eventually determines the functional outcome of a
particular modiﬁcation.
Previously identiﬁed inhibitor of histone acetyltransferases (IN-
HAT) complexes, including SET/TAF-Ib, bind to histones and inhibit
p300/CBP and PCAF-mediated histone acetylation by histone
masking and serve as key regulators in transcriptional repression
and chromatin remodeling [2]. The role of SET/TAF-Ib has been re-
ported in a variety of cellular processes, such as DNA replication,
transcriptional regulation, apoptosis, and carcinogenesis [3–5].
Polycomb group (PcG) and trithorax group (trxG) proteins are
critical regulators of important developmental genes in Drosophilachemical Societies. Published by Eand work as repressors and activators, respectively. Transcriptional
repression of PcG target genes by the polycomb repressive complex
2 (PRC2) along with the PRC1 complex via H3K27me2/3 has been
extensively investigated [6,7]. PRC2 consists of four core subunits
including EZH2, SUZ12, EED, and Rbbp7/RbAp46. Recent observa-
tions suggest that PRC2 is self-recruited to its ownmethylation site
and maintains H3K27me3 propagation during replication [8]. An
antagonistic switch between H3K27me and H3K27Ac during the
regulation of PcG target gene transcription has been reported [9].
Phosphorylation of histone H3, particularly at H3S10, has been
linked to chromosome condensation and segregation during mito-
sis and meiosis [10,11]. A recent report suggested that the associ-
ation between the SR protein splicing factors SRp20 and ASF/SF2
and chromatin is modulated by H3S10 phosphorylation [12].
Crosstalk between H3S10 phosphorylation and H3K14 acetylation
is involved in the release of HP1 from chromatin [13]. It has been
suggested that H3S28 phosphorylation by MSK1 leads to immedi-
ate early (IE) gene promoter remodeling including the 14-3-3 and
SWI/SNF complexes [14].
In this study, we screened the binding speciﬁcities of SET/TAF-Ib
to various modiﬁed histone peptides. We found that SET/TAF-Ib
has a strong afﬁnity for H3K27me1/2/3, resulting in efﬁcient tran-
scriptional repression of target genes. We determined that this
binding is actively disrupted by the transcriptional activation sig-
nal H3S28P, which eventually leads to target gene expression.lsevier B.V. All rights reserved.
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For details of ‘Materials and Methods’ section; see Supplemen-
tary Data.
2.1. Histone peptide array
Modiﬁed histone peptide arrays were provided by Active Motif
(Carlsbad, CA, USA). The array was blocked by incubation in 5%
non-fat dried milk in TBST buffer (10 mM Tris–HCl [pH 8.3],
150 mM NaCl and 0.1% Tween-20) for 1 h at room temperature,
washed three times with TBST buffer, and incubated with puriﬁed
SET/TAF-Ib (3 lg/ll) at 4 C overnight in binding buffer (100 mM
KCl, 20 mM HEPES [pH 7.5], 1 mM EDTA, 0.1 mM DTT and 10%
glycerol). After washing three times with TBST buffer, the array
was incubated with anti-SET/TAF-Ib (Santa Cruz Biotechnology)
at a 1:1000 dilution in TBST buffer at 4 C overnight. Then the array
was washed and incubated with horseradish peroxidase-conju-
gated anti-rabbit (Santa Cruz Biotechnology) for 2 h at room tem-
perature. Finally, the array was visualized using an ECL system
(Santa Cruz Biotechnology).
2.2. Histone peptide pull-down assays
HeLa cell nuclear extract was incubated with 2 lg biotinylated
histone H3 peptide (Millipore) at 4 C overnight. Streptavidin-
coated beads were added, and the reaction was incubated for 1 h
at 4 C. After extensive washing, the bead-bound proteins were
separated by 10% SDS–PAGE gel and analyzed byWestern blot with
anti-SET/TAF-Ib.
2.3. Chromatin immunoprecipitation assays
HeLa cells were treated with 1% formaldehyde for 10 min in
medium at 37 C, followed by the addition of 125 mM glycine for
5 min at room temperature, after which the cells were scraped into
SDS lysis buffer. Sonicated chromatin was immunoprecipitated
with anti-AcH3, H4 (Millipore), and anti-SET/TAF-Ib, which were
subsequently recovered with Protein A/G-agarose beads (GeneDE-
POT). After reversing the cross-links, chromatin was subjected to
proteinase K digestion and the DNA puriﬁed. The DNA fragments
were puriﬁed for polymerase PCR ampliﬁcation. The primer se-
quences used for the quantitative PCR are shown in Supplementary
Data.
3. Results
3.1. SET/TAF-Ib histone peptide array
To investigate the binding speciﬁcities of SET/TAF-Ib to various
modiﬁed histones, we employed modiﬁed histone tail peptide ar-
ray analyses. The array contained 59 acetylation, methylation,
phosphorylation, and citrullination modiﬁcations on the N-termi-
nal tails of histones H2A, H2B, H3, and H4. Each peptide array
had 384 unique histone modiﬁcation combinations in duplicate,
including up to four distinct modiﬁcations on the same 19-mer
peptide (Supplementary Data 2). Eluted and thrombin-cleaved
SET/TAF-Ibwas incubated with arrays in duplicate, and the binding
proﬁles were analyzed (Supplementary Data 3). Previous studies
suggest that SET/TAF-Ib is implicated in transcriptional repression
by inhibiting histone acetylation and associating with various co-
repressors including HDAC1 and 2 [15]. The strong histone binding
properties of SET/TAF-Ib and its role in transcriptional repression
prompted us to further focus on SET/TAF-Ib binding speciﬁcities to-
ward transcriptional repressive markers such as H3K27me amongdifferent histone tail modiﬁcations. H3K27 methylation is a key
marker in PcG-mediated transcriptional repression, which regu-
lates a large number of genes critical in the regulation of develop-
ment and differentiation [16]. As shown in Fig. 1A, SET/TAF-Ib
recognized H3K27me1/2/3 but not H3K27me1/2/3 following
H3S28 phosphorylation (H3S28P). SET/TAF-Ib did not bind
H3S28P when present without further modiﬁcations. Other than
the repressive transcription marker H3K27me, chromatin from
actively transcribed genes was marked by H3K4me and
H3K36me. Consistent with its transcriptional repressive activity,
SET/TAF-Ib did not bind to either transcriptional activation
marker H3K4me1/2/3 or H3K36me1/2/3 (Supplementary
Fig. S1A). Peptidylarginine deiminases convert arginine residues
on substrate proteins to citrulline. Consistent binding patterns
were observed with H3R26me or histone peptides containing
H3R26Citr, and H3K27me modiﬁcations were tested with SET/
TAF-Ib. SET/TAF-Ib bound to H3R26 or H3R26Citr with all
H3K27me1/2/3 modiﬁcations. Adding H3S28P efﬁciently abro-
gated protein binding to double modiﬁcation peptides (Supple-
mentary Fig. S1B). These observations suggest that SET/TAF-Ib
binds H3K27me1/2/3, and that this binding was displaced by near-
by H3S28P. SET/TAF-Ib also showed interactions with either indi-
vidual H2B acetylation (H2BK15Ac) and phosphorylation
(H2BS14P) or di-modiﬁcations (Supplementary Fig. S1C).
3.2. Binding of SET/TAF-Ib to H3K27me1/2/3 peptides was disrupted by
H3S28 phosphorylation
To conﬁrm the binding speciﬁcities of SET/TAF-Ib to H3K27me1/
2/3 and H3S28P peptides, we ﬁrst performed interaction assays be-
tween SET/TAF-Ib and biotin-conjugated H3K27me1/2/3 peptides.
SET/TAF-Ib showed stronger binding to H3K27me3 peptides com-
pared to binding with the H3K27me2 and H3K27me1 peptides
(Fig. 1B). Consistent with the peptide array results, H3S28 phos-
phorylation completely blocked SET/TAF-Ib binding to H3K27me3
(Fig. 1B). Similar results were obtained when HeLa cells were trans-
fected with SET/TAF-Ib, and the cell extracts were incubated with
each biotin-conjugated peptide and probed with SET/TAF-Ib anti-
bodies (Fig. 1C). Previously, we determined that the C-terminus
acidic amino acid domain of SET/TAF-Ib (INHAT domain) is respon-
sible for histone binding and, thus, HAT inhibitory activity [2]. To
further investigate whether the SET/TAF-Ib INHAT domain is
responsible for H3K27me1/2/3 binding, we incubated wild type
SET/TAF-Ib and SET/TAF-IbD3 (C-terminus INHAT domain-deleted)
with H3K27me3 peptides. A domain mapping analysis showed that
binding of SET/TAF-Ib to H3K27me1/2/3 peptides was INHAT do-
main-dependent (Fig. 1D). H3 phosphorylation has been related
to the transcription of IE genes such as c-Jun and c-FOS in response
to mitogens, stress, and differentiation signals. Among the different
kinases involved in H3 phosphorylation,MSK1/2 is themajor kinase
responsible for H3S28 phosphorylation [17,18]. To further evaluate
the disruption of SET/TAF-Ib binding to H3K27me1/2/3 by H3S28
phosphorylation in vivo, we treated cells with anisomycin and
H89. Anisomycin is known to activate stress kinases and phosphor-
ylates MSK1/2 to activate kinase activity [18]. H89 is an inhibitor of
MSK1/2 and blocks H3S28 phosphorylation [19]. When HeLa cells
were treatedwith anisomycin, a signiﬁcant increase in H3S28 phos-
phorylation was observed. Stronger binding of SET/TAF-Ib to
H3K27me1/2/3 was consistently observed with the MSK1/2 inhib-
itory H89 treatment compared to that of DMSO treatment
(Fig. 1E). In contrast, IP with SET/TAF-Ib revealed complete disrup-
tion of SET/TAF-Ib binding to all H3K27me1/2/3 peptideswhen cells
were treated with anisomycin (Fig. 1E). Taken together, these ﬁnd-
ings conﬁrm the results of the peptide arrays in which SET/TAF-Ib
bound to H3K27me1/2/3 and was disrupted by H3S28P.
Fig. 1. Binding of SET/TAF-Ib to methylated H3K27 is disrupted by phosphorylated H3S28. (A) Proﬁles of SET/TAF-Ib binding to the histone tail modiﬁcation in the peptide
array. The enlargement represents SET/TAF-Ib binding to H3K27me1/2/3 and H3K27me1/2/3 with H3S28P, respectively. (B) Puriﬁed GST-SET/TAF-Ib or GST was assayed for
binding to the indicated H3 peptide modiﬁcations. SET/TAF-Ib associated with histone peptides conjugated with biotin was detected by Western blot using anti-SET/TAF-Ib
antibodies. (C) HeLa nuclear extracts were incubated with biotinylated histone H3 peptides containing the indicated modiﬁcations. The peptides and associated proteins were
collected using streptavidin-coated beads and analyzed byWestern blot with anti-SET/TAF-Ib antibodies. (D) GST-SET/TAF-Ib or GST-SET/TAF-IbD3 was assayed for binding to
afﬁnity biotinylated histone H3 peptides. (E) HeLa cells were incubated with anisomycin (10 lM) or MSK inhibitor H89 (10 lM). DMSO alone was added as a control. SET/TAF-
Ib immunoprecipitates were analyzed via Western blot with anti-H3K27me1, anti-H3K27me2, anti-H3K27me3, and anti-H3S28P.
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PRC2 methylates H3K27 and mediates the silencing pathway to
PRC2 target genes such as ATF3, SERPINB2, and BMP2. PRC2 recruit-
ment to these genes is severely disrupted by H3S28 phosphoryla-
tion, and the PRC2 complex is replaced with H3K27 acetylation
by p300/CBP HATs [18,20]. To further investigate whether PRC2
target genes or stress-mediated IE genes are also regulated by
SET/TAF-Ib, expression levels of ATF3, BMP2, and c-myc with SET/
TAF-Ib and sh-SET/TAF-Ib expressed 293T cells were analyzed by
real-time PCR. Interestingly, the PRC2 target genes ATF3 and
BMP2 were downregulated by SET/TAF-Ib and signiﬁcantly upreg-
ulated by SET/TAF-Ib knockdown (Fig. 2A). However, expression
of the stress-responsive IE gene c-myc was not affected by either
overexpression or knockdown of SET/TAF-Ib, supporting speciﬁc
target gene selection by SET/TAF-Ib (Fig. 2A). As reported previ-
ously, activation of MSK1/2 by treating HeLa cells with anisomycin
increased ATF3, BMP, and c-myc expression, whereas inhibitingH3S28P by H89 resulted in downregulation of the same genes
[18] (Fig. 2B). When the SET/TAF-Ib expression level was measured,
neither anisomycin nor H89 treatment affected SET/TAF-Ib expres-
sion (Fig. 2B). These results conﬁrm that the PRC2 target genes
ATF3 and BMP2 are negatively regulated by SET/TAF-Ib and further
suggest a possible role in H3K27me- and H3S28P-mediated tran-
scriptional regulation of the ATF3 and BMP2 genes by SET/TAF-Ib.
3.4. H3S28 phosphorylation enhances H3/H4 acetylation through
disruption of SET/TAF-Ib recruitment
To gain further mechanistic insights into how SET/TAF-Ib is
modulated by H3S28P to regulate target gene expression, ChIP
analyses were used to examine the recruitment of SET/TAF-Ib
and related histone modiﬁcations to the promoters. Promoters of
PcG target genes regulated by SET/TAF-Ib, ATF3 and BMP2, were
analyzed after H3S28P modulation by anisomycin and H89 treat-
ments. Recruitment of SET/TAF-Ib to the ATF3 and BMP2 promoters
increased upon MSK1/2 inhibition by H89 (Fig. 3A and B). In
Fig. 2. SET/TAF-Ib negatively regulates PRC2 target genes. (A) 293T cells were transfected with pNTAP-SET/TAF-Ib and sh-SET/TAF-Ib. Expression levels of ATF3, BMP2, c-myc,
and SET/TAF-Ib were determined via real-time PCR. (B) After HeLa cells were treated with anisomycin and H89, total RNA was isolated for each condition, and real-time PCR
was conducted using ATF3, BMP2, c-myc, and SET/TAF-Ib primers. b-actin was used as the control. ⁄p < 0.05, ⁄⁄p < 0.01, and ⁄⁄⁄p < 0.001.
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regardless of H3S28 phosphorylation status, suggesting that SET/
TAF-Ib is not involved in c-myc expression (Fig. 3C). These results
are consistent with previous reports that ATF3 and BMP2 genes
are silenced by PRC2-mediated H3K27me, which is destabilized
by H3S28P. Our data show that SET/TAF-Ib may play an additional
role repressing these genes in addition to the already identiﬁed
PRC2-mediated target gene silencing. We demonstrated previously
that SET/TAF-Ib is recruited to its target gene and mediates hypo-
H3/H4 acetylation environments [21]. As expected, hypoacetyla-
tion of H3 and H4 was observed in the presence of the H89 treat-
ment, and hyperacetylation was associated with the promoters and
H3S28P induction by anisomycin, possibly through displacement
of SET/TAF-Ib (Fig. 3A and B). H3S28P antagonizes polycomb
silencing by displacing PRC2 complex, recruiting H3K27 acetyla-
tion, and activating transcription [20]. Our ﬁndings suggest that
recruitment and displacement of the INHAT subunit SET/TAF-Ib
may be involved in this process and contribute to PRC2-mediated
repression and HAT-mediated transcriptional activation after
H3S28 phosphorylation. However, c-myc promoters, whose
expression was not affected by SET/TAF-Ib, showed somewhat dif-
ferent H3/H4 acetylation recruitment patterns (Fig. 3C). These re-
sults demonstrate that SET/TAF-Ib acts as a repressor only for
those genes it targets. Consistent observations that SET/TAF-Ib
showed parallel characteristics with PRC2-mediated transcrip-
tional repression of target genes prompted us to investigate the
possible interaction between the PRC2 complex and SET/TAF-Ib
during the silencing process. IP assays using both SET/TAF-Ib and
EZH2 antibodies indicated that SET/TAF-Ib and the PRC2 complexdo not associate with each other (Supplementary Fig. S2). These re-
sults show that SET/TAF-Ib recognizes H3K27me1/2/3 marks mod-
iﬁed by the PRC2 complex and is recruited to the target genes after
H3K27me modiﬁcation to further repress expression. When H3S28
is phosphorylated, SET/TAF-Ib is displaced from the promoter in a
similar way as the PRC2 complex, and H3K27 modiﬁcation is
switched to acetylation by HAT.
3.5. Sequential recruitment of the PRC2 complex and SET/TAF-Ib
The observation that SET/TAF-Ib and the PRC2 complex do not
interact with each other suggests that two different protein com-
plexes independently enforce repressive effects on target gene
transcription. As SET/TAF-Ib recognizes H3K27me1/2/3, we pro-
pose a model in which sequential recruitment occurs between
the PRC2 complex and SET/TAF-Ib to the target gene promoter.
Sequential ChIP and real-time PCR analyses revealed that the
PRC2 complex subunit EZH2 was recruited early to the ATF3 pro-
moter following H89 treatment and with a substantially higher
rate than SET/TAF-Ib (Fig. 4A). Sequential ChIP from 10 to
240 min showed that EZH2 started to be recruited at 20 min, sig-
niﬁcantly jumped between 60 and 120 min, and then reached a
plateau. In contrast, SET/TAF-Ib recruitment increased slowly over
the entire time period and reached approximately half the recruit-
ment level of EZH2 after 240 min (Fig. 4A). The level of H3K27me2
showed a consistent pattern of increasing with EZH2 level, and
acetylated H3 showed a gradual decrease as SET/TAF-Ib level in-
creased (Fig. 4B). Collectively, these results indicate that the
PRC2 complex travels to the promoter of the ATF3 target gene
Fig. 3. Recruitment of SET/TAF-Ib, acetyl-H3, and acetyl-H4 to target gene promoters. (A–C) Recruitment of SET/TAF-Ib, acetyl-H3, and acetyl-H4 to ATF3 (A), BMP2 (B), and c-
myc (C) promoters were analyzed with a ChIP assay and real-time PCR using H89 or anisomycin-treated HeLa cells. ChIP analyses were conducted using anti-SET/TAF-Ib, anti-
acetyl-H3, and anti-acetyl H4. The recruitment of SET/TAF-Ib, acetyl-H3, and H4 to each target gene promoter region was normalized by input. Results are expressed as
mean ± standard deviation; (n = 3). ⁄p < 0.05, ⁄⁄p < 0.01, and ⁄⁄⁄p < 0.001.
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site by H3K27me1/2/3 recognition through the INHAT domain to
facilitate additional repression of target gene transcription.
4. Discussion
In this study, we identiﬁed SET/TAF-Ib binding speciﬁcity for
some of the different histone N-terminal peptide modiﬁcations.
Here, we show that strong SET/TAF-Ib binding to H3K27me1/2/3
was completely disrupted by nearby H3S28P modiﬁcations. Wefound that SET/TAF-Ib targeted the ATF3 and BMP2 promoters high
in H3K27me1/2/3 status that had been modiﬁed by PRC2 recruit-
ment. SET/TAF-Ib recognized H3K27me1/2/3 via the INHAT domain
and was recruited to the target promoters. H3S28 phosphorylation
was induced by MSK1/2 kinases in response to activation signals,
and then the PRC2 complex and SET/TAF-Ib were displaced from
the promoters. It is intriguing that both symmetric and asymmetric
H3R26me2with H3K27me1/2/3 and H3R26Citr with H3K27me1/2/
3 doublemodiﬁcations showed the same binding patterns as that of
H3K27me1/2/3modiﬁcation. PAD4 regulates histoneH3 andH4Arg
Fig. 4. Sequential recruitment of EZH2 and SET/TAF-Ib to the ATF3 promoter. (A and B) Real-time PCR analysis following ChIP assays for EZH2, and SET/TAF-Ib recruitment (A)
or modiﬁcation status of histone AcH3, and H3K27me2 (B) in the ATF3 promoter after H89 treatment for 0–240 min. Results are expressed as mean ± standard deviation;
(n = 3). (C) Model of SET/TAF-Ib target gene regulation by H3K27me1/2/3 and H3S28P.
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and PRMT1 (H4R3) by convertingmethyl-Arg to citrulline. The bind-
ing of SET/TAF-Ib to these modiﬁcations, in addition to H3K27me1/
2/3, was also antagonized by H3S28 phosphorylation. Considering
the effects of H3R26me catalyzed by CARM1 and its implication in
transcriptional activation, these contrastingmodiﬁcations rarely oc-
cur at the same time in vivo.
H4K20me1 has been linked with transcriptional repression and
X inactivation. H4K20me3 is highly enriched at pericentric hetero-
chromatin, imprinted regions, and retrotransposons. It is reason-
able that SET/TAF-Ib showed strong binding speciﬁcities to either
H4K20me1/2/3 alone or with other modiﬁcation such as
H4R24me2. However, it was unexpected that SET/TAF-Ib did not
bind to H3K9me1/2/3 modiﬁcations, which act as strong markers
for transcriptional repression. The reason for this preference be-
tween the two different transcriptional repressive markers needs
further investigation. SET/TAF-Ib showed binding speciﬁcity to-
ward H2BS14phosphorylation. Caspase-3 cleaved kinase MST1 di-
rectly phosphorylates H2BS14, indicating that this modiﬁcation is
associated with apoptotic chromatin condensation [22,23]. Binding
of SET/TAF-Ib to H2BS14P shows that this protein can function as
an inhibitor of caspase-independent apoptotic pathways and as a
transcriptional repressor, suggesting its possible role in this pro-
cess [2].
A previous study demonstrated that SET/TAF-Ib is capable of
transducing the code of unmodiﬁed and hypoacetylated chromatin
into transcriptional repression in higher eukaryotes [15]. Another
study revealed that SET/TAF-Ib binds to the N-terminus of H3,
and this binding is differentially affected by histone modiﬁcations.
In particular, a single phosphorylation antagonizes binding of SET/
TAF-Ib [24]. A complete list of histone phosphorylations and their
effects on cellular signaling has been provided recently [22,25].Interestingly, SET/TAF-Ib showed no binding to H3S10P, H3T11P,
H4S1P, or H2AS1P or almost any of the other modiﬁcation combi-
nations with the above phosphorylations among the other identi-
ﬁed phosphorylation residues (Supplementary Fig. S1D). These
results also suggest that SET/TAF-Ib does not bind to most of the
phosphorylation modiﬁcations in histones, which are somewhat
related to transcriptional activation in different cellular signaling
responses.
In this study, we proﬁled the more comprehensive binding pat-
terns of SET/TAF-Ib to different histone modiﬁcations and further
investigated the detailed mechanism of target gene repression.
We found that SET/TAF-Ib initially recognizes H3K27me1/2/3 by
PRC2 and is recruited to the target gene promoter to foster another
layer of transcriptional repression. This silencing of target genes is
antagonized by MSK1/2-mediated H3S28P and further displace-
ment of PRC2 and SET/TAF-Ib, which eventually recruit HATs and
activate transcription. In conclusion, our results indicate that the
‘‘binary methyl/phosphor switch hypothesis’’ holds true for the
regulation of SET/TAF-Ib-mediated transcriptional repression of
target genes [26].
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